£95.47

MDPI AG Glioblastoma

Price data last checked 94 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£95 today · usual range £0–£0 · best ever £91

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 637 days • 637 data points (No recent data available)

Historical
Generating forecast...
£115.02 £88.22 £94.07 £99.92 £105.76 £111.61 £117.46 09 June 2024 15 November 2024 23 April 2025 29 September 2025 07 March 2026

Price Distribution

Price distribution over 637 days • 5 price levels

Days at Price
Current Price
28 days 199 days 56 days · current 31 days 323 days 0 81 162 242 323 £91 £93 £95 £101 £115 Days at Price

Price Analysis

Most common price: £115 (323 days, 50.7%)

Price range: £91 - £115

Price levels: 5 different prices over 637 days

Description

Glioblastoma is an aggressive incurable primary tumor of the central nervous system. Median overall survival is in the range of 1.5 years even in selected clinical trials populations. Many features contribute to this therapeutic challenge including high intratumoral and intertumoral heterogeneity, resistance to therapy, migration and invasion, immunosuppression. With the access of novel highthroughput technologies, significant progress has been made to understand molecular and immunological signatures underlying the pathology of glioblastoma. Clinical trial designs have shifted from investigating broad "one-for-all" treatment approaches to precision oncology designs. The collection of contributions in this book aim at providing researchers and clinicians an update on different aspects of glioblastoma, i.e. progress in basic, preclinical and clinical research.

Product Specifications

Brand
MDPI AG
Format
Hardcover
Domain
Amazon UK
Release Date
28 July 2020
Listed Since
29 July 2020

Barcode

No barcode data available

Similar Products You Might Like

Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies
98% match

Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies

Springer

£147.07 12 Jan 2026
Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies
98% match

Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies

Springer

£141.86 16 Apr 2026
GLIOBLASTOMA: Risk Factors, Diagnosis & Treatment Options (Cancer Etiology, Diagnosis and Treatment)
98% match

GLIOBLASTOMA: Risk Factors, Diagnosis & Treatment Options (Cancer Etiology, Diagnosis and Treatment)

£90.99 07 Mar 2026
Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)
98% match

Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)

Springer

£76.81 05 Mar 2026
Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)
98% match

Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)

£67.04 12 Jan 2026
Springer - Advances in Biology and Treatment of Glioblastoma
97% match

Springer - Advances in Biology and Treatment of Glioblastoma

Springer

£109.96 10 Mar 2026
Advances in Biology and Treatment of Glioblastoma (Current Cancer Research)
97% match

Advances in Biology and Treatment of Glioblastoma (Current Cancer Research)

Springer

£110.81 10 Mar 2026
Glioblastoma: Methods and Protocols: 1741 (Methods in Molecular Biology, 1741)
97% match

Glioblastoma: Methods and Protocols: 1741 (Methods in Molecular Biology, 1741)

Humana

£5.29 17 Feb 2026
Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)
97% match

Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)

Springer

£107.32 13 Jan 2026
Glioblastoma
97% match

Glioblastoma

Elsevier

£75.29 08 Jan 2026
Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)
97% match

Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)

Springer

£142.76 01 Apr 2026
Humana High-Grade Gliomas: Diagnosis and Treatment Book
97% match

Humana High-Grade Gliomas: Diagnosis and Treatment Book

Humana

£34.33 26 Feb 2026
Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies (Volume 15) (Cancer Sensitizing Agents for Chemotherapy, Volume 15)
97% match

Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies (Volume 15) (Cancer Sensitizing Agents for Chemotherapy, Volume 15)

Academic Press

£112.19 07 Mar 2026
Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America: Volume 32-2 (The Clinics: Surgery, Volume 32-2)
97% match

Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America: Volume 32-2 (The Clinics: Surgery, Volume 32-2)

Elsevier

£89.59 19 Apr 2026
Glioblastoma, Part I: Surgical Management and Adjuncts, An Issue of Neurosurgery Clinics of North America: Volume 32-1 (The Clinics: Surgery, Volume 32-1)
97% match

Glioblastoma, Part I: Surgical Management and Adjuncts, An Issue of Neurosurgery Clinics of North America: Volume 32-1 (The Clinics: Surgery, Volume 32-1)

Elsevier

£85.79 10 Apr 2026
High-Grade Gliomas: Diagnosis and Treatment (Current Clinical Oncology)
97% match

High-Grade Gliomas: Diagnosis and Treatment (Current Clinical Oncology)

Humana

£156.39 09 Mar 2026
Gliomas: Symptoms, Diagnosis & Treatment Options (Cancer Etiology, Diagnosis and Treatments)
97% match

Gliomas: Symptoms, Diagnosis & Treatment Options (Cancer Etiology, Diagnosis and Treatments)

£120.15 13 Jan 2026
New Techniques for Management of ‘Inoperable’ Gliomas
97% match

New Techniques for Management of ‘Inoperable’ Gliomas

Academic Press

£100.98 02 Mar 2026
New Insights into Glioblastoma: Diagnosis, Therapeutics and Theranostics
97% match

New Insights into Glioblastoma: Diagnosis, Therapeutics and Theranostics

£117.69 13 Jan 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
96% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£213.13 06 Feb 2026
Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)
96% match

Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)

Humana

£124.65 30 Mar 2026
Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy
96% match

Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy

Springer

£113.09 16 Mar 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
96% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£247.73 05 Feb 2026
New Targeting in The Reversal of Resistant Glioblastomas (Volume 14) (Cancer Sensitizing Agents for Chemotherapy, Volume 14)
96% match

New Targeting in The Reversal of Resistant Glioblastomas (Volume 14) (Cancer Sensitizing Agents for Chemotherapy, Volume 14)

Academic Press

£110.99 01 Mar 2026